JPRN-UMIN000020199
Completed
Phase 2
Hypofractionated proton beam therapy for localized prostate cancer - Hypofractionated proton beam therapy for localized prostate cancer
ConditionsProstate cancer
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Prostate cancer
- Sponsor
- Aizawa hospital
- Enrollment
- 120
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) With active other cancers 2\) With severe uncontrolled diabetes 3\) With severe heart disease, or some serious complications, i.e., SLE, Scleroderma, interstitial pneumonia 4\) Allergic to radiation 5\) Previous surgical treatment for prostate disease before enrollment 6\) Previous chemotherapy (except holmonal therapy)for prostate cancer before enrollment 7\) Previous radiotherapy to pelvis 8\) With implantable cardioverter defibrillator or permanent pacemaker 9\) Considered that participation in this trial is difficult because of psychiatric symptoms or psychosis 10\) Cannot be held rest for about 60 minutes 11\) Cannot be implanted Au marker in the prostate 12\) Unsuitable for enrollment judged by principal investigator
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 2
Hypofractionated Proton Beam Therapy of 51.6Gy(RBE) in 12 fractions (3 weeks) with real-time-image gated spot-scanning system for non-metastatic prostate cancer (T1c-T4N0M0)Prostate cancerJPRN-UMIN000046163Kyoto Prefectural University of Medicine Department of Radiology180
Completed
Not Applicable
A clinical trial of proton radiotherapy with local immunotherapy for recurrent cases with hepatocellular carcinomaJPRN-UMIN000002863Proton Medical Research Center, University of Tsukuba10
Completed
Not Applicable
Radiotherapy with scanning beam protons for locally advanced prostate cancer or localised prostate cancer with risk factorsProstate cancerCancerMalignant neoplasm of prostateISRCTN78176828niversity Hospital Essen (Universitatsklinikum Essen) (Germany)240
Completed
Not Applicable
Multi-institutional study to evaluate the usefulness of proton therapy for intracranial tumors using normal tissue complication probability modelJPRN-UMIN000052664Hokkaido university68
Completed
Phase 2
Phase II study of hypofractionated proton beam therapy for localized prostate cancerProstate cancerJPRN-UMIN000017679Proton Medical Research Center, University of Tsukuba125